Why the study?
Higher resting heart rate in patients with HF and sinus rhythm is associated with increased mortality, prompting evaluation of heart rate lowering medications and heart rate control at hospital discharge.
What is the rate of heart rate control and its predictors at discharge in patients hospitalized for HFrEF with sinus rhythm?
What is the rate of heart rate control and its predictors at discharge in patients hospitalized for HFrEF with sinus rhythm?
Heart rate control after hospitalization for HFrEF is often unsatisfactory, largely due to suboptimal beta-blocker dosing and underuse of other heart rate lowering drugs like ivabradine.
Answers are grounded in this paper and cite their sources.
Suboptimal discharge HR control despite beta-blockers signals titration gaps; leaves open whether targeted interventions improve real-world outcomes in HFrEF.
BACKGROUND: Higher resting heart rate (HR) in patients with heart failure (HF) and sinus rhythm (SR) is associated with increased mortality. In patients hospitalized for HF, the aim herein, was to assess the use and dosage of guideline-recommended HR lowering medications, HR control at discharge and predictors of HR control. METHODS: In the present study, were Polish participants of the European Society of Cardiology HF Long-Term (ESC-HF-LT) Registry. Those selected were hospitalized for HF, with reduced ejection fraction (HFrEF) and SR at discharge (n = 236). The patients were divided in two groups ( < 70 and ≥ 70 bpm). Logistic regression was used to identify the predictors of HR ≥ 70 bpm. RESULTS: Of patients with HFrEF and SR, 59% had HR ≥ 70 bpm at hospital discharge. At discharge, 96% and only 0.5% of the patients with HFrEF and SR received beta-blocker and ivabradine, respectively. In the HF groups < 70 and ≥ 70 bpm, only 11% and 4% of patients received beta-blocker target doses, respectively. There was no difference in the use of other guideline-recommended medications. Age, New York Heart Association class, HR on admission and lack of HR lowering medications were predictors of discharge HR ≥ 70 bpm. CONCLUSIONS: Heart rate control after hospitalization for HFrEF is unsatisfactory, which may be attributed to suboptimal doses of beta-blockers, and negligence in use other HR lowering drugs (including ivabradine).
No takes yet. Share an insight, caveat, or question.
Tymińska et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: